Coherus Biosciences Inc. (CHRS)
NASDAQ · Healthcare
Coherus Biosciences Inc. Gross Profit 2012–2025
Coherus Biosciences Inc. annual/quarterly gross profit history and growth rate from 2019 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Coherus Biosciences Inc. gross profit for the quarter ending March 31, 2026 was 8.5 M, a 71.78% increase year-over-year.
- Coherus Biosciences Inc. gross profit for the twelve months ending March 31, 2026 was 28.2 M, a 48.39% decrease year-over-year.
- Coherus Biosciences Inc. annual gross profit for 2025 was 28.4 M, a 60.56% increase from 2024.
- Coherus Biosciences Inc. annual gross profit for 2024 was 17.7 M, a 82.02% decrease from 2023.
- Coherus Biosciences Inc. annual gross profit for 2023 was 98.3 M, a 30.30% decrease from 2022.
- Coherus Biosciences Inc. annual gross profit for 2022 was 141.0 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Coherus Biosciences Inc. Gross Profit — FAQ
Coherus Biosciences Inc. (CHRS) gross profit over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Coherus Biosciences Inc.'s gross profit?
Coherus Biosciences Inc. (CHRS) reported gross profit of $28M for fiscal 2025.
Where can I see CHRS's gross profit history?
The chart and table above show Coherus Biosciences Inc.'s gross profit by year and by quarter, including the growth rate.